Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in Patients With Inflammatory Bowel Disease: A Single-Center Experience

Clinical Gastroenterology and Hepatology

Volumn 15, Issue 4, 2017, Pages 597-599

  Chin, Samantha M ^a   Sauk, Jenny ^b   Mahabamunuge, Jasmine ^a   Kaplan, Jess L ^a   Hohmann, Elizabeth L ^a   Khalili, Hamed ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISONE;

ADULT; AGED; ANUS FISTULA; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLOSTRIDIUM DIFFICILE INFECTION; CROHN DISEASE; DISEASE ASSOCIATION; FECAL MICROBIOTA TRANSPLANTATION; HUMAN; INFLAMMATORY BOWEL DISEASE; MEDICAL HISTORY; OUTCOME ASSESSMENT; PATIENT SAFETY; PERIANAL ABSCESS; RECURRENT INFECTION; ULCERATIVE COLITIS; ADOLESCENT; CLOSTRIDIUM INFECTION; COMPLICATION; FEMALE; MALE; MIDDLE AGED; PROCEDURES; PROSPECTIVE STUDY; RECURRENT DISEASE; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CLOSTRIDIUM INFECTIONS; FECAL MICROBIOTA TRANSPLANTATION; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85015607792     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2016.11.028     Document Type: Article

References (7)

1. 1 Youngster, I., Mahabamunuge, J., Systrom, H.K., et al. Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection. BMC Med, 14, 2016, 134.
2. 2 Youngster, I., Sauk, J., Pindar, C., et al. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin Infect Dis 58 (2014), 1515–1522.
3. 3 Nguyen, G.C., Kaplan, G.G., Harris, M.L., et al. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol 103 (2008), 1443–1450.
4. 4 Moayyedi, P., Surette, M.G., Kim, P.T., et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 149 (2015), 102–109.
5. 5 Rossen, N.G., Fuentes, S., van der Spek, M.J., et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology 149 (2015), 110–118.
6. 6 Fischer, M., Kao, D., Kelly, C., et al. Fecal microbiota transplantation is safe and efficacious for recurrent or refractory Clostridium difficile infection in patients with inflammatory bowel disease. Inflamm Bowel Dis 22 (2016), 2402–2409.
7. 7 Khoruts, A., Rank, K.M., Newman, K.M., et al. Inflammatory bowel disease affects the outcome of fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol 14 (2016), 1433–1438.